Simpson Curran bought RGNX
January 6, 2026 · Form 4 insider transaction
Simpson Curran bought 233,651 shares of REGENXBIO Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
233,651
Price
$0.00
Total value
N/A
InsiderSimpson Curran
RoleOfficer, Director
CompanyREGENXBIO Inc. (RGNX)
SecurityStock Options (Right to buy)
Transaction codeA: Grant or award
Transaction dateJanuary 6, 2026
Filing dateJanuary 8, 2026
Shares owned after233,651
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 6, 2027 while the optionee provides continuous service to the Issuer.